Attached files
| file | filename |
|---|---|
| 10-K - 10K 2016 - GENETHERA INC | genethera10k2016_10k.htm |
| EX-31.1 - EXHIBIT 31 - GENETHERA INC | exhibit31_ex31z1.htm |
| EX-21 - EXHIBIT 2.1 - GENETHERA INC | exhibit21_ex21.htm |
Exhibit 32.1
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
UNDER SECTION 906 OF THE
SARBANES OXLEY ACT OF 2002, 18 U.S.C. § 1350
In connection with this annual report on Form 10-K of GeneThera, Inc. (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of Dr. Antonio Milici, Principal Executive Officer and Tannya L. Irizarry, Principal Financial Officer of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his/her knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: September 10, 2018
/s/Dr. Antonio Milici
Dr. Antonio Milici
Chief Executive Officer
Principal Executive Officer
/s/Tannya L. Irizarry
Tannya L. Irizarry
Chief Financial Officer
Principal Financial Officer